Astonea Labs has clarified the signing authority for its FY26 audited financial results, confirming director Mr. Pardeep Dalal's authorization. The company reported a net profit of ₹4.51 crore for FY26. An earlier factory fire in April 2026 resulted in a loss of ₹9.39 crore.
Astonea Labs Clarifies Financial Result Signing Authority
Astonea Labs reported a net profit after tax of ₹4.51 crore for the financial year ended March 31, 2026. The company's total income stood at ₹148.10 crore. Total assets were reported at ₹146.26 crore.
Reader Takeaway: Procedural clarification on financials; factory fire impact and insurance claim are key.
What just happened
Astonea Labs Ltd has provided a clarification to the BSE regarding the signing authority for its audited financial results for the fiscal year ended March 31, 2026. The company confirmed that its Board of Directors authorized Mr. Pardeep Dalal, a Director, to sign these financial results during a meeting on May 25, 2026. This action ensures compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Why this matters
This clarification addresses potential regulatory observations and confirms the validity of the submitted financial statements. While the financial figures themselves remain unchanged, the confirmation provides procedural clarity for investors. The company reported a net profit of ₹4.51 crore for FY26, with total income at ₹148.10 crore and total assets at ₹146.26 crore.
The backstory
The company experienced a significant fire at its factory on April 27, 2026, which caused damage to plant, machinery, and inventory. This incident resulted in a reported loss of ₹9.39 crore. Astonea Labs has initiated an insurance claim for this damage. Management has stated that the incident does not impact the company's status as a going concern.
Separately, the company had approved a variation in the utilization of its IPO proceeds on February 27, 2026. This included a new investment of ₹6.25 crore in Damaira Pharmaceuticals Private Limited, a decision that has been fully implemented.
During the 2025-26 fiscal year, Astonea Labs also established a wholly-owned subsidiary, 'Astonea LLC', in the USA to support its export activities.
What changes now
No changes have been made to the previously disclosed financial information. The clarification primarily serves to confirm the authorized signatory for the audited FY26 financial results.
Risks to watch
Investors should closely monitor the progress and outcome of the insurance claim related to the factory fire. The ability of the company to recover from the operational disruption caused by the fire and its impact on future production and profitability remains a key concern.
Peer comparison
(No specific peer comparison data available in the filing).
Context metrics (time-bound)
- Factory Fire Incident: April 27, 2026
- Reported Loss from Fire: ₹9.39 crore
- IPO Proceeds Variation Approval: February 27, 2026
- Investment in Damaira Pharmaceuticals: ₹6.25 crore
- Financial Year End: March 31, 2026
- FY26 Net Profit: ₹4.51 crore
- FY26 Total Income: ₹148.10 crore
- FY26 Total Assets: ₹146.26 crore
What to track next
Investors should track the resolution of the insurance claim for the factory fire and any updates on its impact on the company's operational capacity and financial performance. Monitoring the performance of the newly incorporated US subsidiary and the effectiveness of the IPO proceeds utilization will also be important.